GlassScriptPhysician profile
John Popovich
NPI 1306914833
$1,035.02
in general payments reported to CMS, 2019-2025
12 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.48 · 2020: $50.00 · 2022: $335 · 2023: $201 · 2024: $261 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550 · Grant: $32.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.61 |
| Grant | $32.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $137.33 | 2023 | Channel Drain |
| Abbvie INC. | $124.09 | 2022 | |
| Si-Bone, INC. | $118.41 | 2022 | |
| Abiomed | $118.04 | 2024 | Impella |
| Axonics, INC. | $110.52 | 2024 | Bulkamid |
| Momentis Surgical INC. | $92.00 | 2022 | |
| Allergan, INC. | $68.48 | 2019 | |
| Zimmer Biomet Holdings, INC. | $63.50 | 2023 | Tapestry |
| Boston Scientific Corporation | $62.86 | 2025 | General - Pain Management |
| Hologic Sales and Service, LLC | $57.36 | 2025 | Aptima |
| Covidien LP | $50.00 | 2020 | |
| Cook Incorporated | $32.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Popovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.